Acadia Healthcare (NASDAQ:ACHC) Trading 21.9% Higher – Still a Buy?

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shot up 21.9% during trading on Tuesday . The company traded as high as $13.89 and last traded at $14.2350. 1,678,534 shares traded hands during mid-day trading, a decline of 37% from the average session volume of 2,675,270 shares. The stock had previously closed at $11.68.

Analysts Set New Price Targets

Several research analysts have recently issued reports on ACHC shares. Leerink Partners reaffirmed a “market perform” rating and issued a $14.00 target price (down previously from $25.00) on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Bank of America cut shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $21.50 to $13.00 in a research note on Wednesday, December 3rd. Raymond James Financial set a $17.00 target price on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Barclays reduced their price target on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Thursday, December 4th. Finally, Cowen reiterated a “reduce” rating on shares of Acadia Healthcare in a report on Friday. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.92.

Acadia Healthcare Trading Up 24.2%

The stock has a market capitalization of $1.34 billion, a price-to-earnings ratio of 12.38, a PEG ratio of 3.06 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. The business has a 50 day simple moving average of $14.64 and a 200-day simple moving average of $19.84.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. The business had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.Acadia Healthcare’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently added to or reduced their stakes in the company. Allworth Financial LP lifted its stake in Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after acquiring an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Hantz Financial Services Inc. boosted its holdings in Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares during the last quarter. CWM LLC grew its position in Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after purchasing an additional 1,349 shares in the last quarter. Finally, Quent Capital LLC acquired a new stake in Acadia Healthcare in the 3rd quarter valued at $71,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.